Selegiline hydrochloride 30 mg Oral Capsules

Selegiline hydrochloride is a medication primarily used in the management of Parkinson's disease, a neurodegenerative disorder characterized by tremors, stiffness, and difficulty with balance and coordination. Selegiline acts as a selective monoamine oxidase inhibitor, specifically targeting the MAO-B enzyme. By inhibiting this enzyme, selegiline helps to increase the levels of dopamine in the brain, which can alleviate some of the symptoms associated with Parkinson's disease. Additionally, selegiline may have neuroprotective properties and is thought to slow the progression of the disease to some extent.

The 30 mg oral capsule formulation of selegiline hydrochloride provides a solid dosage form that is easy to administer. The medication is encapsulated within two gelatin or vegetarian shells, depending on the patient's dietary restrictions or preferences. These capsules are designed to be swallowed whole, ensuring that patients receive an accurate and consistent dose of the active ingredient. The encapsulation also helps to mask any unpleasant taste and can protect the medication from degradation by stomach acid, ensuring that it reaches the small intestine where it can be absorbed effectively.

For patients, it is important to take selegiline hydrochloride as prescribed by their healthcare provider. This medication can interact with certain foods and other medications, so it is crucial to discuss dietary restrictions and current medications with a healthcare professional. Patients should also be aware of potential side effects, which can include dizziness, nausea, and insomnia, among others. Regular monitoring by a healthcare provider is recommended to adjust the dosage as needed and to manage any adverse effects.

Prescribers should consider the patient's overall health status, including their history of cardiovascular disease, as selegiline can have hypertensive effects if used improperly. It is also important to monitor for potential drug interactions, particularly with other antidepressants or medications that can affect serotonin levels, to avoid serotonin syndrome. Dosage adjustments may be necessary for patients with liver or kidney impairment.

Bayview Pharmacy's team of compounding pharmacists is dedicated to providing high-quality, customized medications to meet the specific needs of each patient. If you have any questions about the selegiline hydrochloride 30 mg oral capsules or their use in treating Parkinson's disease, please reach out to us for more information. We are here to support both patients and prescribers with expert advice and personalized care.

Selegiline hydrochloride is a monoamine oxidase inhibitor (MAOI) that is primarily used to treat Parkinson's disease. It works by increasing levels of certain chemicals in the brain that help to reduce the symptoms of Parkinson's disease, such as tremors and stiffness. However, due to its mechanism of action, selegiline can interact with a variety of medications and substances, which can lead to serious, sometimes life-threatening, reactions.

One of the most significant interactions is with other MAOIs, which can lead to a hypertensive crisis—a rapid and dangerous increase in blood pressure. Therefore, patients should not take selegiline with other MAOIs, or within two weeks of stopping or starting another MAOI. Similarly, selegiline should not be taken with sympathomimetic amines, including decongestants and cold medications containing pseudoephedrine or phenylephrine, as these can also cause a hypertensive crisis.

Selegiline can also interact with antidepressants. Combining selegiline with serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, or other drugs that affect serotonin levels can lead to serotonin syndrome, a potentially life-threatening condition. Symptoms of serotonin syndrome include confusion, hallucination, seizure, extreme changes in blood pressure, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, muscle spasm or stiffness, tremor, incoordination, stomach cramp, nausea, vomiting, and diarrhea. Patients should inform their healthcare provider of all antidepressants they are taking before starting selegiline.

Selegiline should be used with caution in patients taking opioid medications, as there is a risk of severe and potentially fatal reactions. This includes, but is not limited to, medications such as meperidine, tramadol, methadone, and propoxyphene. Patients should discuss all pain medications with their healthcare provider to ensure safety.

Patients should also avoid consuming foods and beverages high in tyramine, as selegiline can inhibit its metabolism, leading to a hypertensive crisis. High-tyramine foods include, but are not limited to, aged cheeses, cured meats, fermented products, soy products, tap beers, and red wines. Patients should be provided with a comprehensive list of foods to avoid and should consult with their healthcare provider or a dietitian if they have any questions about dietary restrictions.

Selegiline may also interact with other medications that affect blood pressure, including antihypertensive drugs, which could lead to an additive hypotensive effect. Patients should be monitored closely for signs of low blood pressure, such as dizziness, lightheadedness, and fainting, especially when starting or increasing the dose of selegiline.

It is important for patients to inform their healthcare provider of all medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements, as well as any changes in their health status, to avoid potential drug interactions. If you have any questions or concerns about the use of selegiline hydrochloride 30 mg oral capsules or potential drug interactions, please reach out to us at Bayview Pharmacy for further assistance.

Selegiline hydrochloride is an active pharmaceutical ingredient encapsulated within oral capsules, which are solid dosage forms. These capsules are made up of two halves, typically composed of either gelatin or a vegetarian substitute, that are joined together to enclose the medication. This design allows for the medication to be ingested easily and comfortably, as the smooth capsule shell facilitates swallowing. The capsule form also ensures that each dose contains a precise amount of Selegiline hydrochloride, which is crucial for maintaining the efficacy and safety of the treatment.

Selegiline hydrochloride functions as a selective monoamine oxidase inhibitor (MAOI), specifically targeting the MAO-B enzyme. By inhibiting this enzyme, Selegiline hydrochloride helps to increase the levels of certain chemicals in the brain, such as dopamine, which can be beneficial in the management of Parkinson's disease and major depressive disorder. In Parkinson's disease, the increased dopamine levels can help to alleviate some of the symptoms associated with the condition, such as tremors and muscle stiffness. For depression, enhancing the levels of neurotransmitters can improve mood and overall feelings of well-being.

The 30 mg oral capsule formulation of Selegiline hydrochloride is designed to provide a convenient once-daily dosing regimen, which can improve patient adherence to the medication. Patients should be carefully monitored for any potential side effects, and the use of this medication should be avoided in combination with certain other drugs, such as other MAOIs or serotonergic agents, due to the risk of serious drug interactions.

For patients and prescribers considering the use of Selegiline hydrochloride 30 mg oral capsules, it is essential to understand the specific actions and potential interactions of this medication. As compounding pharmacists at Bayview Pharmacy, we are available to answer any questions and provide additional information to ensure the safe and appropriate use of this formulation. Please feel free to reach out to us for further assistance.